Literature DB >> 23546821

The history of Lynch syndrome.

C Richard Boland1, Henry T Lynch.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23546821      PMCID： PMC3720817          DOI： 10.1007/s10689-013-9637-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


× No keyword cloud information.
  60 in total

1.  Conversion of diploidy to haploidy.

Authors:  H Yan; N Papadopoulos; G Marra; C Perrera; J Jiricny; C R Boland; H T Lynch; R B Chadwick; A de la Chapelle; K Berg; J R Eshleman; W Yuan; S Markowitz; S J Laken; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

2.  Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

Authors:  H Elsaleh; D Joseph; F Grieu; N Zeps; N Spry; B Iacopetta
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

3.  Origins of the Leeds Castle Polyposis Group.

Authors:  Kay Neale; Steffen Bülow
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

4.  History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer.

Authors:  Henry T Lynch; Giuseppe Cristofaro; Paul Rozen; Hans Vasen; Patrick Lynch; Jukka-Pekka Mecklin; Jim St John
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

5.  Heredity and adenocarcinoma of the colon.

Authors:  H T Lynch; A J Krush
Journal:  Gastroenterology       Date:  1967-10       Impact factor: 22.682

6.  [Familial incidence of double malignancies].

Authors:  M Kartagener; J Wyler
Journal:  Schweiz Med Wochenschr       Date:  1966-02-19

7.  Hereditary factors in cancer. Study of two large midwestern kindreds.

Authors:  H T Lynch; M W Shaw; C W Magnuson; A L Larsen; A J Krush
Journal:  Arch Intern Med       Date:  1966-02

8.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

9.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

10.  Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.

Authors:  Christian N Arnold; Ajay Goel; C Richard Boland
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396
View more
  31 in total

Review 1.  Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.

Authors:  Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2015-12-02

2.  SEOM clinical guideline on hereditary colorectal cancer (2019).

Authors:  C Guillén-Ponce; E Lastra; I Lorenzo-Lorenzo; T Martín Gómez; R Morales Chamorro; A B Sánchez-Heras; R Serrano; M C Soriano Rodríguez; J L Soto; L Robles
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

3.  Recurrent mismatch binding by MutS mobile clamps on DNA localizes repair complexes nearby.

Authors:  Pengyu Hao; Sharonda J LeBlanc; Brandon C Case; Timothy C Elston; Manju M Hingorani; Dorothy A Erie; Keith R Weninger
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

Review 4.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

Review 5.  Chromatin remodeling and mismatch repair: Access and excision.

Authors:  Eva M Goellner
Journal:  DNA Repair (Amst)       Date:  2019-10-17

Review 6.  The changing landscape of Lynch syndrome due to PMS2 mutations.

Authors:  J Blount; A Prakash
Journal:  Clin Genet       Date:  2018-03-15       Impact factor: 4.438

Review 7.  The evolution of colorectal cancer genetics-Part 2: clinical implications and applications.

Authors:  Andrew T Schlussel; Ronald A Gagliano; Susan Seto-Donlon; Faye Eggerding; Timothy Donlon; Jeffrey Berenberg; Henry T Lynch
Journal:  J Gastrointest Oncol       Date:  2014-10

Review 8.  New insights into the mechanism of DNA mismatch repair.

Authors:  Gloria X Reyes; Tobias T Schmidt; Richard D Kolodner; Hans Hombauer
Journal:  Chromosoma       Date:  2015-04-11       Impact factor: 4.316

9.  Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case.

Authors:  Jinru Shia; Zsofia K Stadler; Martin R Weiser; Efsevia Vakiani; Robin Mendelsohn; Arnold J Markowitz; Moshe Shike; C Richard Boland; David S Klimstra
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

10.  Recent discoveries in the molecular genetics of Lynch syndrome.

Authors:  C Richard Boland
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.